GlaxoSmithKline invests $360 million in post-Brexit UK manufacturing
July 27, 2016 at 02:05 AM EDT
LONDON (Reuters) - GlaxoSmithKline plans 275 million pounds ($361 million) of new investments at three drug manufacturing sites in Britain, signaling its confidence in the country despite last month's vote to leave the European Union.
